Taboo no more: Leaders gather to discuss women's health [Globe and Mail, The (Toronto, Canada)]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Globe and Mail, The
Manulife, left, and Janet Ko from The Menopause Foundation of Canada. Jenna Muirhead/The Globe and Mail Infertility, postpartum depression, perimenopause and menopause: For decades, women's health issues like these were ignored or deemed hysteria by doctors. While attitudes have improved over the years, we need to do more to improve the quality of care for women across the country, health experts told a packed audience at a recent event at The Globe and Mail in Toronto. “For too long, women's health was a blind spot in our health care system. Women weren't taken seriously when they sought medical help,” said Health Minister Marjorie Michel at Women's health: Bridging the gaps in knowledge and care on Oct. 24. “Because of a legacy of inequity, women's unique health needs continue to be misdiagnosed, misrepresented and misunderstood,” she added. There is reason to be optimistic, though. More women are entering the health care field, said Ms. Michel, with women holding 79 per c
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Study that said glyphosate herbicide is safe retracted 25 years after publication [Yahoo! Finance Canada]Yahoo! Finance Canada
- Bayer Starts Phase IIa Study for Treatment of Patients With Alport SyndromeBusiness Wire
- Trump administration backs Bayer as Roundup fight moves toward Supreme Court [FOX Business Network]FOX Business Network
- RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary EndpointsBusiness Wire
- Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.MarketBeat